key: cord-0948735-ye47ypep
authors: Ambrosi, Cecilia; Prezioso, Carla; Checconi, Paola; Scribano, Daniela; Sarshar, Meysam; Capannari, Maurizio; Tomino, Carlo; Fini, Massimo; Garaci, Enrico; Palamara, Anna Teresa; De Chiara, Giovanna; Limongi, Dolores
title: SARS-CoV-2: Comparative analysis of different RNA extraction methods
date: 2020-11-04
journal: J Virol Methods
DOI: 10.1016/j.jviromet.2020.114008
sha: f4d1d92e2e165d1beed9874ed66e2438bbf8564d
doc_id: 948735
cord_uid: ye47ypep

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of the COVID-19 pandemic. Although other diagnostic methods have been introduced, detection of viral genes on oro- and nasopharyngeal swabs by reverse-transcription real time-PCR (rRT-PCR) assays is still the gold standard. Efficient viral RNA extraction is a prerequisite for downstream performance of rRT-PCR assays. Currently, several automatic methods that include RNA extraction are available. However, due to the growing demand, a shortage in kit supplies could be experienced in several labs. For these reasons, the use of different commercial or in-house protocols for RNA extraction may increase the possibility to analyze high number of samples. Herein, we compared the efficiency of RNA extraction of three different commercial kits and an in-house extraction protocol using synthetic ssRNA standards of SARS-CoV-2 as well as in oro-nasopharyngeal swabs from six COVID-19-positive patients. It was concluded that tested commercial kits can be used with some modifications for the detection of the SARS-CoV-2 genome by rRT-PCR approaches, although with some differences in RNA yields. Conversely, EXTRAzol reagent was the less efficient due to the phase separation principle at the basis of RNA extraction. Overall, this study offers alternative suitable methods to manually extract RNA that can be taken into account for SARS-CoV-2 detection.

At the end of 2019, Coronavirus disease 2019 (COVID-19), a highly infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was firstly reported in Wuhan, China and rapidly spread from its origin to other countries throughout the world [1] . SARS-CoV-2 infection is transmitted from human to human mainly through respiratory droplets and aerosol as well as direct or indirect contact [2] . patients are the main source of transmission, whereas asymptomatic and pre-symptomatic infected persons might also be potential sources of infection [3] [4] [5] [6] . These features may explain the sudden epidemic spreading of the virus. Although several efforts are being focused on fast development of novel rapid and reliable diagnostic tests, to date, real-time reverse transcriptase-polymerase chain reaction (rRT-PCR) based assays on respiratory specimens is still considered the gold standard to detect SARS-CoV-2-infection [7] . rRT-PCR is highly sensitive and specific and, compared to other available viral detection methods (e.g. viral antigen detection, standard plaque assay, serology, electron microscopy), is significantly faster with a lower potential for contaminations and/or errors. Undoubtedly, rRT-PCR performance can be greatly affected by the efficiency of the viral RNA extraction procedures. Several methods are used in molecular biology to isolate RNA from samples, such as the guanidinium thiocyanate-phenol-chloroform and anion-exchange resin extractions. Thus, J o u r n a l P r e -p r o o f many commercial kits exploit these methods to allow a fast, sensitive and reproducible detection of viral RNA.

However, SARS-CoV-2 infection has challenged, in every aspect, the global health systems including the ability to quickly provide reagents to labs around the world for molecular diagnostic tests. In this scenario, although rRT-PCR is the most valuable, computerized tomography (CT) scans of lungs have been used to overcome the shortening of rRT-PCR supplies [8, 9] . However, COVID-19 diagnosis by CT scans was often difficult in asymptomatic patients and increases the risk of false-negatives. In a pandemic period, when the shortage of diagnostic kits is predictable, the worldwide sharing of different protocols for RNA extraction and gene amplification among laboratories is strongly required. Along this line, reliable protocols for viral RNA extraction are crucial for those molecular laboratories not equipped with automated nucleic acid extraction systems. Therefore, the present study is aimed at evaluating and optimizing the recovery of SARS-CoV2 RNA from nasopharyngeal swabs using three different commercial kits as well as providing a suitable in-house extraction protocol. After protocol optimization, the four methods were evaluated and compared using different concentrations of two synthetic ssRNA standards of SARS-CoV-2 [10] and Allplex 2019-nCoV assay (Seegene, Seoul, South Korea) and an in-house rRT-PCR [11] for detection. The performance of the analyzed methods was also tested on positive clinical specimens.

Nasopharyngeal rayon swabs (Cod. 26061 Rayon) were sampled according to WHO guidelines (https://apps.who.int/iris/handle/10665/331058). Swabs were placed in saline (0.9% NaCl) and stored in appropriate containers for transport of biological samples in accordance with UN 3373 and transported to the laboratory of microbiology within one hour.

The Iris -CoV-2 study entitled "Studio osservazionale di sorveglianza epidemiologica SARS-Cov2 su operatori sanitari e pazienti di una struttura di medicina riabilitativa" was approved by the Ethical Committee on March 25 th , 2020. Written informed consent was provided by participants; enrolled subjects were: 100 real-life, 56 patients and 224 healthcare professionals from IRCCS San Raffaele, Pisana, Rome, Italy. Subjects were swabbed three times in a three-months follow-up; repeatedly screening for SARS-CoV-2 was chosen to contain SARS-Cov2 transmission.

J o u r n a l P r e -p r o o f Two synthetic ssRNA, an 880 nt of SARS-CoV-2, and Australia/VIC01/2020 were used as positive controls to compare the performance of different extraction protocols [10, 12] . Control and total RNAs from nasopharyngeal swabs were extracted using Qiamp DSP Virus Spin kit (Qiagen, Hilden, Germany, Cat.61704), 

J o u r n a l P r e -p r o o f Two different quantified synthetic ssRNA standards for SARS-CoV-2 were prepared by serial 10-fold serial dilutions in RNAse free water, Australia/VIC01/2020 SARS-CoV-2 RNA and EURM-019 [10, 12] . Dilutions ranged from 2 10 0 to 2 10 7 copies/µl. After dilution, both standards were tested in one step rRT-PCR using Allplex 2019-nCoV assay, a multiplex for simultaneous detection of the envelope (E) gene, RNA-dependent RNA polymerase gene (RdRp), and nucleocapsid (N) gene and using the US CDC panel for detection of SARS-CoV-2 which detects three regions of the virus nucleocapsid (N) gene, named N1, N2 and N3 (Table   S1 ). A linear amplification was achieved over a 6-log dynamic range from 2  10 1 to 2 × 10 7 copies/µl for the two assays; calculated PCR efficiency, by means of the following formula E=10(−1/slope) [13] , of each standard ranged from 103,3% to 113,5% using Allplex 2019-nCoV assay ( Fig. 1A and B) , and from 105,0% to 107,9% using the US CDS panel assays for detection of SARS-CoV-2 ( Fig. 1C and D) . Noteworthy, the Allplex 2019-nCoV assay couldn't detect the N gene within the synthetic ssRNA standard for SARS-CoV-2 EURM-019, while it was detected by all sets of primers of the US CDC panel for detection of SARS-CoV-2 (Fig. 1D ).

The limit of detection (LoD) was 2  10 1 copies/µl (Fig. 1) . Based on the data from standard curve estimations, two different amounts, 2  10 2 and 8  10 5 copies, were arbitrary chosen to compare the efficiency of RNA recovery from different extraction methods. RdRp and N genes) . The same 10-fold dilutions of (C) Australia/VIC01/2020 SARS-CoV-2 RNA and (D) EURM-019 were analyzed using the US CDS panel assays for detection of SARS-CoV-2 (N gene detected by primer pairs for N1, N2 and N3). The linear regression analysis is shown only for the N1 primer pair. For each assay, the linear correlation coefficients, PCR efficiency E=10(−1/slope), R 2 and slope were calculated. In the first rRT-PCR round, no signal could be detected using the Total RNA Purification Kit, while variable Ct values were observed for the IC using the other extraction methods. Therefore, we introduced and/or extended some steps to the provided protocols to improve the performance of the extraction methods, as summarized in Table 1 . Missing bars correspond to >40 Ct for Allplex 2019-nCoV assay or negative for the US CDC panel for SARS-CoV-2. Cp, copies.

Among the 56 oro-nasopharyngeal swabs collected from patients admitted at the IRCCS San Raffaele Pisana Rome, Italy, six were found positive. Positivity to SARS-CoV-2 was also laboratory-confirmed by the local Azienda Sanitaria Locale (ASL) ASL ROMA 3 (Italian Local Health Authority). Samples in saline were extracted with the four methods, following manufacturer's instructions and the optimized extraction protocols. Extracts were analyzed by both rRT-PCR assays, run in parallel with synthetic RNA standards for SARS-CoV-2. Results were in agreement with our previous data on the extraction with synthetic standards, showing an improvement in RNA extraction yield (corresponding to lower Ct values) for the OPT protocols using both rRT-PCR approaches (Fig. 3) . However, although both rRT-PCR methods are highly sensitive for the detection of RNAs,

The COVID-19 pandemic is still ongoing worldwide, causing severe illness and death [2] . Although several antigen-detecting rapid diagnostic tests have been developed [14] , detection of viral RNA by rRT-PCR from oro-nasopharyngeal swabs is still the method more sensitive to confirm SARS-CoV-2 suspected infections [8, 15, 16] . However, although rRT-PCRs were proven to be efficient and sensitive approaches for COVID-19 diagnosis, the extraction efficiency influences significantly the yield of RNA. Thus, the method used for RNA extraction is the most important variable to determine the positivity of sample for SARS-CoV-2 genome, especially for those labs that are not equipped with automated nucleic acid extraction systems. Therefore, labs approach was proven to be the less efficient. These results were predictable since commercial kits exploit the binding capacity of silica-gel affinity columns to selectively entrap, allowing the elution of RNA from samples.

Vice versa, the guanidinium thiocyanate-phenol-chloroform extraction technique is based on the principle that under acidic conditions RNA remains in the aqueous phase, whereas DNA and proteins are captured within the interphase or in the lower organic phase, favoring its recovery by precipitation with isopropanol [17] . As a matter of fact, the efficiency of isolated RNA by EXTRAzol is lower than that extracted by column-based methods. Therefore, caution should be exercised for the detection of SARS-CoV-2 with EXTRAzol, since in the presence of low or very low viral loads it can go undetected.

The rRT-PCR assays to detect SARS-CoV-2 were developed to detect genus-and species-specific targets.

Among those, the N gene was chosen because it is highly abundant during viral replication and conserved among coronaviruses [18, 19] . Detection of the N gene using the synthetic ssRNA standard EURM-019 and the Allplex 2019-nCoV assay failed; instead, it was appreciable using the US CDC rRT-PCR panel assay ( . Being the sequence of the primer pair targeting the N gene under Seegene patent, we could not give a satisfactory explanation for the lack of its detection using EURM-019. Conversely, we observed amplification of this gene in clinical samples using the Allplex 2019-nCoV assay (Fig. 3) . However, several labs reported cases in which the N gene was the only gene detected at high Ct (>36) which was, instead, undetectable by re-testing some subjects the day after (unpublished observations). Although conserved among coronaviruses, it has been shown that the N gene exhibited a great variability [16, 20, 21] . Besides the variability of replicate specimens and of the run's volume reactions, it can be hypothesized that the uncertainty on N positive results could be linked to a transient stage of virus-host contact and its transitory detection to its high abundancy. This aspect of SARS-CoV-2 infection deserves further investigations.

In conclusion, three of the four RNA extraction methods following the optimized protocols herein provided were proven to be useful for the detection of the SARS-CoV-2 genome by rRT-PCR approaches, although with some differences in the yield of RNA obtained for the Total RNA Purification Kit (Norgen). Due to the phase separation principle at the basis of RNA extraction, EXTRAzol reagent displayed constantly the lowest yield, likely affecting the performance of rRT-PCR. Thus, based on the results of this study, we strongly recommend that rRT-PCR assays should validate more brands for RNA extraction kits to deal with the great demand of them for community screenings and possible future outbreaks. Although the Allplex 2019-nCoV assay failed to detect the N gene within the ssRNA, its performance was accurate for clinical samples, as previously reported [22] . However, maximal caution is needed when detection of SARS-CoV-2 genes occurs at high Ct values, for which re-testing should be recommended. In addition, with the increasing knowledge on N gene sequence variability and stability, we do believe that the primer pair chosen for its detection by the Allplex 2019-nCoV assay should be optimized to increase further its performance and accuracy as well as avoiding false-positive results.

Note added in proof: During revision of this manuscript, Seegene developed a new commercial kit for rRT-PCR in which they changed the enzyme, probes, and amplicon sizes (N. cat. RV10248X). 

BHQ1-3' 2019-nCoV_N2-F 2019-nCoV_N2 Forward Primer 5

China Novel Coronavirus Investigating and Research Team. A Novel Coronavirus from Patients with Pneumonia in China

Presumed asymptomatic carrier transmission of COVID-19

Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic

Asymptomatic cases in a family cluster with SARS-CoV-2 infection

WHO: World Health Organization

The global emergency of novel coronavirus (SARS-CoV-2): an update of the current status and forecasting

Three Italy" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia

EURM-019 single stranded RNA (ssRNA) fragments of SARS-CoV-2

CDC: Center for Disease Control and Prevention

TWIST BIOSCIENCES for Australia/VIC01/2020: Available online: www.twistbioscience.com

Quantification on the LightCycler instrument

SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients

The establishment of reference sequence for SARS-CoV-2 and variation analysis

The single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction: twenty-something years on

Identification of a coronavirus transcription enhancer

Probable pangolin origin of SARS-CoV-2 associated with the COVID-19 outbreak

Genomic variance of the 2019-nCoV coronavirus

The Nucleocapsid Protein of SARS-CoV-2: a Target for Vaccine Development

SARS-CoV-2 Foch Hospital study group. The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?

The authors would like to acknowledge the infrastructure support provided by the IRCCS San Raffaele Pisana, 00166 Rome, Italy to perform this study.J o u r n a l P r e -p r o o f